THERAVANCE BIOPHARMA, INC. (TBPH) Net income 2016–2025
THERAVANCE BIOPHARMA, INC. (TBPH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$105.9MFY2025 · since FY2016: -$190.7M → $105.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $105.9M | +287.7% |
| FY2024 | -$56.4M | -2.2% |
| FY2023 | -$55.2M | -106.3% |
| FY2022 | $872.1M | +537.3% |
| FY2021 | -$199.4M | +28.3% |
| FY2020 | -$278.0M | -17.6% |
| FY2019 | -$236.5M | -9.7% |
| FY2018 | -$215.5M | +24.5% |
| FY2017 | -$285.4M | -49.7% |
| FY2016 | -$190.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice